Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Feb
6
2012
Maryland Poised to Develop Offshore Wind Resources McDermott Will & Emery
Mar
26
2012
The IRS Retains Control of Tax Issues Relating to the Section 1603 Grant McDermott Will & Emery
May
23
2012
EPA Releases Final Permitting Guidance for Fracing with Diesel Fuel McDermott Will & Emery
Jan
11
2018
FDA 2017 Year in Review McDermott Will & Emery
Aug
22
2012
United States' First Offshore Wind Farm Obtains Critical Federal Approval McDermott Will & Emery
Feb
20
2018
District Court Issues Opinion in Old Charter Bourbon False Advertising Class Action McDermott Will & Emery
Jun
17
2021
Paris Court of Appeals Rejects Pharmaceutical Supplementary Protection Certificate Applications McDermott Will & Emery
Jun
28
2013
Claim Term Can Have Different Constructions Depending Upon Context In Patent Claims McDermott Will & Emery
Jun
25
2021
McDermottPlus Check-Up: June 25, 2021 Infrastructure, Cost Sharing & Vaccination Goal McDermott Will & Emery
Jul
21
2013
French Administrative Supreme Court (Conseil d'Etat) Orders Change to Rules Authorizing Hydrocarbon Exploration Drilling McDermott Will & Emery
Jun
6
2018
TTB to Allow Proprietors to Request Alternating Premise Variances for Storage of Tax- and Non-Tax-Determined Commodities McDermott Will & Emery
Jul
30
2013
Department of Justice Launches an Antitrust Investigation into Pressure Pumping Services Used in Hydraulic Fracturing McDermott Will & Emery
Sep
26
2013
IRS Issues Additional Guidance on When Construction Begins for Purposes of Production Tax Credit, Investment Tax Credit McDermott Will & Emery
Oct
15
2021
McDermottPlus Check-Up: October 15, 2021 McDermott Will & Emery
Oct
1
2018
Recent Retailer Direct Shipping Opinion Illustrates Stakes in Upcoming Supreme Court Review McDermott Will & Emery
Jan
9
2014
Greenhouse Gas Limits for New Power Plants – Comments due to EPA (Environmental Protection Agency) by March 10, 2014 McDermott Will & Emery
Dec
10
2021
McDermottPlus Check-Up: December 10, 2021 McDermott Will & Emery
Dec
12
2018
FDA Issues Real-World Evidence Framework for Drugs and Biologics McDermott Will & Emery
Apr
15
2022
Revised CDC Guidance for Prescribing Opioids Emphasizes Physician Judgment, Reflects Concerns About Misapplication of Earlier Guidance McDermott Will & Emery
Oct
5
2014
A Warehouse Full of Unapproved Genetically-Modified Seeds; Now What?, Syngenta Seeds, Inc. v. Bunge North America, Inc. McDermott Will & Emery
May
1
2019
China's Pharmaceutical Marketing Authorisation Holder Mechanism McDermott Will & Emery
Jun
7
2022
Alcohol Suppliers Hit with ADA Website Accessibility Lawsuits McDermott Will & Emery
Dec
1
2014
Significant Number of Dawn Raids Shows Increased Antitrust and Criminal Law Enforcement in Italian Pharmaceutical Sector McDermott Will & Emery
Jan
30
2015
Statute Intended to Close Deepsouth Loophole Given Broad Interpretation: Promega Corp. v. Life Techs. Corp. McDermott Will & Emery
Aug
26
2022
Departments Issue Final Rule Implementing Certain No Surprises Act Provisions McDermott Will & Emery
Aug
20
2019
TTB Label Approval System Survives First Amendment Challenge from DC Brewery McDermott Will & Emery
Dec
29
2022
Welcome (but Last Minute) Relief for Prescription Drug Reporting Originally Due December 27 McDermott Will & Emery
Dec
1
2015
The Medicines Company v. Hospira, Inc.: Federal Circuit to Consider On-Sale Bar En Banc McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins